By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Chugai Pharmaceutical Co., Ltd. (Japan) 

1-9, Kyobashi 2-chome

Chuo-ku  Tokyo  104-8301  Japan
Phone: 81-3-3281-6611 Fax: 81-3-3281-2828


SEARCH JOBS


Industry
Biotechnology

Segment
Pharmaceuticals





Company News
Athersys, Inc. (ATHX) And Chugai Pharmaceutical Co., Ltd. (Japan) Enter License Agreement And Collaboration To Develop Multistem Cell Therapy For Ischemic Stroke In Japan 3/2/2015 7:12:37 AM
Drug Giant Chugai Pharmaceutical Co., Ltd. (Japan) Will Invest $476 Million to Expand Singapore R&D Unit 2/2/2015 7:05:19 AM
Chugai Pharmaceutical Co., Ltd. (Japan) Licenses ISPRI/Optimatrix Platform From EpiVax, Inc. For De-Risking Biologics 10/30/2014 9:27:40 AM
Disappointment Looms As Roche (RHHBY) Drops Plans To Bid For The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) 8/26/2014 6:00:53 AM
Conflicting Reports Surface Over Roche Holding AG (RHHBF.PK)'s $10 Billion Deal, Chugai Pharmaceutical Co., Ltd. (Japan) Denies Talks 8/18/2014 5:54:39 AM
Roche (RHHBY) May Gobble Up The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan) For $10 Billion 8/15/2014 10:51:33 AM
Helsinn Group And Marketing Enter Into Agreement For Marketing Rights Of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) In The UK And Ireland And For Palonosetron Monotherapy In The UK 7/17/2014 9:14:54 AM
Chugai Pharmaceutical Co., Ltd. (Japan) Invests $30 Million To Build China Marketing/Distribution 12/30/2013 1:29:24 PM
Roche (RHHBY) Has No Plan to Sell Chugai Pharmaceutical Co., Ltd. (Japan) Stake 4/12/2013 7:54:53 AM
Chugai Pharmaceutical Co., Ltd. (Japan) and Debiopharm Announce an Exclusive License Agreement for Anti-Cancer Agent, FF284 1/8/2013 10:48:22 AM
1234567
//-->